A successful case of extracorporeal membrane oxygenation for COVID-19: walking home without oxygen supplementation
AuthorTran, Dena H
Peng, Carol Chiung-Hui
Wolde-Rufael, Daniel A
Chow, R Dobbin
Verceles, Avelino C
JournalJournal of Community Hospital Internal Medicine Perspectives
PublisherTaylor and Francis Inc.
MetadataShow full item record
AbstractIntroduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged from Wuhan, China in December 2019 and is the strain of coronavirus that causes coronavirus disease 2019 (COVID-19). Approximately one-third of the patients with COVID-19 require intensive care unit (ICU) admission, and almost 30% of the patients develop acute respiratory distress syndrome (ARDS). Extracorporeal membrane oxygenation (ECMO) is used as salvage therapy for severe ARDS. The role of ECMO in the treatment of COVID-19 remains unclear, although there is emerging evidence that this approach may be an effective salvage therapy for severe ARDS. Case Presentation: We present a case of a previously healthy 39-year-old Hispanic male who presented to the hospital with flu-like symptoms, including headache, fatigue, and myalgia for 8 days in late April 2020. He denied dyspnea on exertion. The patient's symptoms progressed, resulting in pneumonia and acute respiratory distress syndrome (ARDS). The patient was managed with prone positioning, convalescent plasma and veno-venous extracorporeal membrane oxygenation (VV-ECMO) for 35 days. The patient successfully recovered and was able to ambulate independently and was discharged home from an acute care hospital without oxygen supplementation on hospital day 63. Conclusion: We present one of the first few documented cases of ECMO for severe ARDS due to COVID-19. After a prolonged hospital course requiring VV-ECMO, the patient was discharged home from an acute care hospital without oxygen requirement and ambulated independently, likely as a result of daily aggressive mobility-focused rehabilitation.
Rights/Terms© 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center.
acute respiratory distress syndrome
extracorporeal membrane oxygenation
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16144
- A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.
- Authors: Rajdev K, Farr LA, Saeed MA, Hooten R, Baus J, Boer B
- Issue date: 2020 Jan-Dec
- Extracorporeal membrane oxygenation for coronavirus disease 2019-associated acute respiratory distress syndrome: Report of two cases and review of the literature.
- Authors: Wen JL, Sun QZ, Cheng Z, Liao XZ, Wang LQ, Yuan Y, Li JW, Hou LS, Gao WJ, Wang WJ, Soh WY, Li BF, Ma DQ
- Issue date: 2021 Mar 16
- Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid-19 or influenza: A single-center registry study.
- Authors: Jäckel M, Rilinger J, Lang CN, Zotzmann V, Kaier K, Stachon P, Biever PM, Wengenmayer T, Duerschmied D, Bode C, Staudacher DL, Supady A
- Issue date: 2021 Jun
- Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.
- Authors: Lewis D, Fisler G, Schneider J, Sweberg T, Murphy K, Sathya C, Silver P, Taylor MD
- Issue date: 2020 Sep
- Prone position ventilation and femoro-femoral veno-venous extracorporeal membrane oxygenation for COVID-19 treatment.
- Authors: Maeda A, Nabeya D, Nagano H, Yagi N, Miyagi T, Kishaba T
- Issue date: 2021 Jan